Medicare Enrolled
Dr. George Chow, MD
Neurology · Tarzana, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chow?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chow
Dr. George Chow is a neurology specialist in Tarzana, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chow performed 618 Medicare services across 420 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chow received a total of $15,465 from 86 pharmaceutical and/or device companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chow is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in CA
$15,465 industry payments
Medicare Practice Summary
Medicare Utilization ↗618
Medicare services
Top 43% in CA for neurology
420
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $102 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
139 | $146 | $195 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
49 | $37 | $50 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
26 | $413 | $625 |
| New patient office visit, complex (60-74 min) | 21 | $180 | $350 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
14 | $176 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,465
Total received (2018-2024)
Avg $2,209/year across 7 years
Top 18% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
788
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,199 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$267 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,430
2023
$2,327
2022
$3,013
2021
$2,665
2020
$2,062
2019
$1,792
2018
$1,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$240
ABBVIE INC.
$188
Teva Pharmaceuticals USA, Inc.
$174
ACADIA Pharmaceuticals Inc
$170
Novartis Pharmaceuticals Corporation
$168
Otsuka America Pharmaceutical, Inc.
$163
Celgene Corporation
$110
Biogen, Inc.
$94
UCB, Inc.
$86
Lilly USA, LLC
$85
Kyowa Kirin, Inc.
$76
Lundbeck LLC
$76
Acorda Therapeutics, Inc
$67
Merz Pharmaceuticals, LLC
$67
ARGENX US, INC.
$66
MDD US Operations, LLC
$63
ANI Pharmaceuticals, Inc.
$61
Genentech USA, Inc.
$61
EMD Serono, Inc.
$60
SK Life Science, Inc.
$49
Neurocrine Biosciences, Inc.
$37
Alnylam Pharmaceuticals Inc.
$36
Eisai Inc.
$29
Cadwell Industries, INC
$28
Genentech, Inc.
$21
AstraZeneca Pharmaceuticals LP
$21
Sumitomo Pharma America, Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Axsome Therapeutics, Inc.
$18
Azurity Pharmaceuticals, Inc.
$17
Vanda Pharmaceuticals Inc.
$14
Neurelis, Inc.
$14
Amgen Inc.
$13
Top 3 companies account for 24.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,202
Teva Pharmaceuticals USA, Inc.
$1,029
Biogen, Inc.
$995
AbbVie Inc.
$845
ABBVIE INC.
$736
Amgen Inc.
$701
UCB, Inc.
$610
SK Life Science, Inc.
$598
Kyowa Kirin, Inc.
$488
ACADIA Pharmaceuticals Inc
$470
PFIZER INC.
$377
Sunovion Pharmaceuticals Inc.
$328
Lilly USA, LLC
$296
US WorldMeds, LLC
$281
AstraZeneca Pharmaceuticals LP
$274
Otsuka America Pharmaceutical, Inc.
$273
Alexion Pharmaceuticals, Inc.
$269
Biohaven Pharmaceuticals, Inc.
$267
Acorda Therapeutics, Inc
$266
Genentech USA, Inc.
$243
Adamas Pharmaceuticals, Inc.
$242
ARGENX US, INC.
$226
Eisai Inc.
$223
Amneal Pharmaceuticals LLC
$201
EMD Serono, Inc.
$199
Alnylam Pharmaceuticals Inc.
$198
Neurocrine Biosciences, Inc.
$184
Celgene Corporation
$175
Biohaven Pharmaceutical Holding Company Ltd.
$161
MITSUBISHI TANABE PHARMA AMERICA, INC.
$151
Allergan, Inc.
$140
Lundbeck LLC
$138
MDD US Operations, LLC
$131
ARBOR PHARMACEUTICALS, INC.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$126
Sumitomo Pharma America, Inc.
$114
Janssen Pharmaceuticals, Inc
$113
Nevro Corp.
$108
Abbott Laboratories
$98
Merz Pharmaceuticals, LLC
$98
Horizon Therapeutics plc
$94
Supernus Pharmaceuticals, Inc.
$89
Assertio Therapeutics, Inc.
$88
GENZYME CORPORATION
$83
EISAI INC.
$77
Merz North America, Inc.
$75
Neurelis, Inc.
$73
Banner Life Sciences, LLC
$70
BANNER LIFE SCIENCES, LLC
$69
Bausch Health US, LLC
$68
ANI Pharmaceuticals, Inc.
$61
Zyla Life Sciences, Inc.
$60
AbbVie, Inc.
$58
JAZZ PHARMACEUTICALS INC.
$51
ASSERTIO THERAPEUTICS, Inc.
$48
Zyla Life Sciences
$45
Axsome Therapeutics, Inc.
$42
Avanir Pharmaceuticals, Inc.
$34
Collegium Pharmaceutical, Inc.
$30
Azurity Pharmaceuticals, Inc.
$30
Cadwell Industries, INC
$28
Impax Laboratories, Inc.
$26
Mitsubishi Tanabe Pharma America, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$24
Catalyst Pharmaceuticals, Inc.
$24
Octapharma USA, Inc.
$24
Paratek Pharmaceuticals, Inc.
$22
Promius Pharma LLC
$22
UPSHER-SMITH LABORATORIES LLC
$22
Genentech, Inc.
$21
Boston Scientific Corporation
$20
TerSera Therapeutics LLC
$20
Upsher-Smith Laboratories LLC
$20
IMPEL PHARMACEUTICALS INC.
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
LivaNova USA, Inc.
$19
CATALYST PHARMACEUTICALS, INC.
$19
Egalet US Inc
$19
Avion Pharmaceuticals
$19
Vertical Pharmaceuticals, LLC
$17
Cala Health, Inc.
$17
Vertiflex, Inc.
$17
Arbor Pharmaceuticals, Inc.
$15
Tactile Systems Technology Inc
$15
Vanda Pharmaceuticals Inc.
$14
AngioDynamics, Inc.
$13
Top 3 companies account for 20.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AURYON LASER SYSTEM 100-120 VAC · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · Betaseron · Briviact · CALA TRIO · CAMBIA · COMIRNATY · COPAXONE · Cambia · DIVIGEL · DUOPA · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · ERGOMAR · FLEXITOUCH · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gocovri · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · Senza · Soliris · Sunosi · Superion ISS · TECFIDERA · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
469
Per 100K population
4.8
County median income
$87,760
Nearest hospital
PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chow is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chow experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chow performed 369 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chow receive payments from pharmaceutical companies?
Yes. Dr. Chow received a total of $15,465 from 86 companies across 788 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chow's costs compare to other neurologists in Tarzana?
Dr. Chow's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tarzana
Browse neurologists in Tarzana ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology